Poster Session
Issue Date: August 01, 2019
Published Online: November 15, 2019
Updated: November 26, 2019
Effects of Sertraline Treatment for Young Children With Fragile X Syndrome (FXS): Family Perspectives
Author Affiliations & Notes
  • Dominican University of California, San Rafael, CA, USA
  • Dominican University of California, San Rafael, CA, USA
  • Dominican University of California, San Rafael, CA, USA
  • Dominican University of California, San Rafael, CA, USA
  • Dominican University of California, San Rafael, CA, USA
Article Information
Intellectual Disabilities / Mental Health / Neurologic Conditions / Pediatric Evaluation and Intervention / Basic Research
Poster Session   |   August 01, 2019
Effects of Sertraline Treatment for Young Children With Fragile X Syndrome (FXS): Family Perspectives
American Journal of Occupational Therapy, August 2019, Vol. 73, 7311505083. https://doi.org/10.5014/ajot.2019.73S1-PO1022
American Journal of Occupational Therapy, August 2019, Vol. 73, 7311505083. https://doi.org/10.5014/ajot.2019.73S1-PO1022
Abstract

Date Presented 04/04/19

Fragile X syndrome (FXS) is the most common inherited form of intellectual and developmental disability and the most common single gene cause of autism spectrum disorder (ASD). FXS has been widely researched, primarily via a medical model. Yet, the FXS literature lacks occupation-based outcome measures capturing improvements in everyday life. This research examined individual cases as part of a clinical trial and compared standardized testing results to occupation-based family interviews.

Additional Authors and Speakers: Laura Hess

Primary Author and Speaker: Tracy Ye

Additional Authors and Speakers: Decerie Mendoza, Martina Dualan, Elena Javier